| 04.11 06:52 | dpa-AFX: *BERENBERG RAISES HALEON PRICE TARGET TO 456 (454) PENCE - 'BUY' |
| 04.11 06:43 | dpa-AFX: *BARCLAYS RAISES HALEON PRICE TARGET TO 407 (406) PENCE - 'OVERWEIGHT' |
| 01.11 14:00 | dpa-AFX: *RBC RAISES HALEON PRICE TARGET TO 350 (330) PENCE - 'SECTOR PERFORM' |
| 31.10 08:25 | dpa-AFX: Haleon Plc Q3 Organic Revenue Up 6.1% |
| 31.10 08:08 | dpa-AFX: *HALEON POSTS Q3 ORGANIC REVENUE GROWTH OF 6.1% |
| 17.10 07:15 | dpa-AFX: *BERENBERG RAISES HALEON PRICE TARGET TO 454 (447) PENCE - 'BUY' |
| 08.10 09:54 | dpa-AFX: *UBS RAISES HALEON PRICE TARGET TO 445 (410) PENCE - 'BUY' |
| 08.10 08:23 | dpa-AFX: *DEUTSCHE BANK RESEARCH HEBT ZIEL FÜR HALEON AUF 375 (340) PENCE - 'HOLD' |
| 08.10 08:23 | dpa-AFX: *DEUTSCHE BANK RESEARCH RAISES HALEON PRICE TARGET TO 375 (340) PENCE - 'HOLD' |
| 08.10 06:36 | dpa-AFX: *BARCLAYS CUTS HALEON PRICE TARGET TO 406 (407) PENCE - 'OVERWEIGHT' |
| 01.10 15:03 | dpa-AFX: *HALEON APPOINTS CHRISTINE JAKOVCICAS AS GENERAL MANAGER, HALEON CANADA |
| 01.10 08:26 | dpa-AFX: Pfizer's Total Interest In Haleon To Reduce From Approx. 22.6% To Approx. 15.0% |
| 27.09 12:44 | dpa-AFX: Haleon To Buy Addl. 33% Stake In China JV, Totaling 88% |
| 27.09 12:19 | dpa-AFX: *HALEON TO INCREASE STAKE IN CHINA JV TO 88% |
| 13.09 05:46 | dpa-AFX: *JEFFERIES RAISES HALEON PRICE TARGET TO 450 (410) PENCE - 'BUY' |
| 10.09 13:44 | dpa-AFX: *BOFA RAISES HALEON PRICE TARGET TO 440 (400) PENCE - 'BUY' |
| 03.09 14:57 | dpa-AFX: Haleon Announces Launch Of Eroxon In The U.S. For Preorder Without Prescription |
| 03.09 14:19 | dpa-AFX: *HALEON ANNOUNCES LAUNCH OF EROXON AVAILABLE FOR U.S. PREORDER WITHOUT PRESCRIPTION |
| 06.08 10:14 | dpa-AFX: *GOLDMAN SENKT HALEON AUF 'NEUTRAL' (BUY) - ZIEL 380 (360) PENCE |
| 06.08 10:14 | dpa-AFX: *GOLDMAN CUTS HALEON TO 'NEUTRAL' (BUY) - PRICE TARGET 380 (360) PENCE |
|
|
